ArticleFrontiers in immunology2026

CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC.

Jianying Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.